Use of Mutations in Bacteria as Indicators of Carcinogenic Potential

  • R. D. Callander
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 94 / 2)

Abstract

The use of bacterial mutation systems to detect chemical carcinogens began in the late 1940s, shortly after the demonstration that carcinogenic nitrogen and sulphur mustards induced gene mutations (and chromosome rearrangements) in the germ cells of Drosophila melanogaster (Auerbach and Robson 1946). The rationale for such use stems from Boveri’s theory of the mutational origin of cancer (see Wolf 1974), which in turn was refined by Bauer (1928) and gained increasing acceptance with successive comparative studies of mutagens and carcinogens in the early 1950s.

Keywords

Ames Test Mutation Assay Fluctuation Test Forward Mutation Bacterial Assay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ames BN (1971) The detection of chemical mutagens with enteric bacteria. In: Hollaender A (ed) chemical mutagens: principles and methods for their detection, vol 1. Plenum, New York, pp 267–282Google Scholar
  2. Ames BN, Lee FD, Durston WE (1973 a) An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci USA 70:782–786PubMedCrossRefGoogle Scholar
  3. Ames BN, Durston WE, Yamasaki E, Lee FD (1973 b) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 70:2281–2285PubMedCrossRefGoogle Scholar
  4. Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347–364PubMedGoogle Scholar
  5. Arcos JC, Argus MF, Wolf G (1968) Chemical induction of cancer, vol 1. Academic, New YorkGoogle Scholar
  6. Ashby J (1986) Letter to the editor. Mutagenesis 1:309–317PubMedCrossRefGoogle Scholar
  7. Ashby J (1989) The evaluation of volatile chemicals for mutagenicity. Letter to the editor. Mutagenesis 4:160–162PubMedCrossRefGoogle Scholar
  8. Ashby J, Tennant RW (1988) Chemical structure, Salmonella mutagenicity, and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res 204 : 17–115PubMedCrossRefGoogle Scholar
  9. Ashby J, Lefevre PA, Styles JA, Charlesworth J, Paton D (1982) Comparisons between carcinogenic potency and mutagenic potency to Salmonella in a series of derivatives of 4-dimethylaminoazobenzene (DAB). Mutat Res 93:67–81PubMedCrossRefGoogle Scholar
  10. Ashby J, Callander RD, Rose FL (1985) Weak mutagenicity to Salmonella of the formaldehyde-releasing anti-tumour agent hexamethylmelamine. Mutat Res 142:121–125PubMedCrossRefGoogle Scholar
  11. Auerbach C, Robson JM (1946) Production of mutations by allyl isothiocyanate. Nature 54:81–82Google Scholar
  12. Balbinder E, Kerry D (1984) A new strain of Salmonella typhimurium reverted by mitomycin C and N-methyl-N'-nitro-N-nitrosoguanidine — a possible universal tester for mutagenic compounds. Mutat Res 130:315–320PubMedGoogle Scholar
  13. Bartsch H, Malaveille C, Montesano R (1975) Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains. Int J Cancer 15:429–437PubMedCrossRefGoogle Scholar
  14. Bartsch H, Camus A-M, Malaveille C (1976) Comparative mutagenicity of N- nitrosamines in a semi-solid and in a liquid incubation system in the presence of rat or human tissue fractions. Mutat Res 37:149–162PubMedCrossRefGoogle Scholar
  15. Bauer KH (1928) Mutationstheorie der Geschwulstentstehung. Springer, Berlin Heidelberg New YorkGoogle Scholar
  16. Berry DJ, Litchfield MH (1985) A review of the current regulatory requirements for mutagenicity testing. In: Ashby J, de Serres FJ, Draper M, Ishidate M Jr, Margolin BH, Matter BE, Shelby MD (eds) Evaluation of short-term tests for carcinogens. Report of the international programme on chemical safety’s collaborative study on in vitro assays. Elsevier, Amsterdam, pp 727–740 (Progress in mutation research, vol 5)Google Scholar
  17. Bjorseth A, Eidsa G, Gether J, Landmark L, Moller M (1982) Detection of mutagens in complex samples by the Salmonella assay applied directly on thin-layer chromatography plates. Science 215:87–89PubMedCrossRefGoogle Scholar
  18. Bridges BA, Mottershead RP, Green MHL, Gray WJH (1973) Mutagenicity of dichlorvos and methyl methanesulphonate for Escherichia coli WP2 and some derivatives deficient in DNA repair. Mutat Res 19:295–303PubMedCrossRefGoogle Scholar
  19. Bridges BA, Zeiger E, McGregor DB (1981) Summary report on the performance of bacterial mutation assays. In: de Serres FJ, Ashby J (eds) Evaluation of short-term tests for carcinogens. Report of the international collaborative program. Elsevier, New York, pp 49–67 (Progress in mutation research, vol 1)Google Scholar
  20. Brusick D (1980) Principles of genetic toxicology. Plenum, New York, pp 232–235Google Scholar
  21. Burdette WJ (1955) The significance of mutation in relation to the origin of tumours: a review. Cancer Res 15:201–226PubMedGoogle Scholar
  22. Callander RD (1986) Observed convergence of the Salmonella plate and pre-incubation assays when employing varying levels of S9. Mutagenesis 1:439–443PubMedCrossRefGoogle Scholar
  23. Clarke CH, Wade MJ (1975) Evidence that caffeine, 8-methoxypsoralen and steroidal diamines are frameshift mutagens for E. coliKll. Mutat Res 28:123–125PubMedCrossRefGoogle Scholar
  24. Clive D, McCuen R, Spector JFS, Piper C, Mavournin KH (1983) Specific gene mutations in L5178Y cells in culture: a report of the US EPA Gene-Tox Program. Mutat Res 115:225–251PubMedGoogle Scholar
  25. Connor TH, Legator MS (1984) The intraperitoneal host-mediated assay. In: Kilbey BJ, Legator M, Nichols W, Ramel C (eds) Handbook of mutagenicity test procedures, 2nd edn. Elsevier, Amsterdam, pp 643–654Google Scholar
  26. EEC (1983) Commission directive 83/467/EEC: annex V to council directive 67/548/EEC on the classification, packaging and labelling of dangerous substances. Official Journal of the European Communities, no L 257,16 September 1983, Brussels, pp 21–23Google Scholar
  27. Forster R (1986) Mutagenicity of benzyl chloride to Salmonella. Mutagenesis 1:72–73Google Scholar
  28. Gabridge MG, Legator MS (1969) A host-mediated microbial assay for the detection of mutagenic compounds. Proc Soc Exp Biol Med 130:831–834PubMedGoogle Scholar
  29. Garner RC, Miller EC, Miller J A (1972) Liver microsomal metabolism of aflatoxin Bx to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res 32:2058–2066PubMedGoogle Scholar
  30. Gatehouse D (1978) Detection of mutagenic derivatives of cyclophosphamide and a variety of other mutagens in a microtitre fluctuation test, without microsomal activation. Mutat Res 53:289–296PubMedGoogle Scholar
  31. Gatehouse D (1987) Guidelines for testing of environmental agents: critical features of bacterial mutation assays. Mutagenesis 2:397–409PubMedCrossRefGoogle Scholar
  32. Gatehouse DG, Delow GF (1979) The development of a microtitre fluctuation test for the detection of indirect mutagens, and its use in the evaluation of mixed enzyme induction of the liver. Mutat Res 60:239–252PubMedCrossRefGoogle Scholar
  33. Gatehouse DG, Paes DJ (1983) A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction. Carcinogenesis 4:347–352PubMedCrossRefGoogle Scholar
  34. Green MHL, Muriel WJ (1976) Mutagen testing using trp + reversion in Escherichia coli. Mutat Res 38:2–32Google Scholar
  35. Green MHL, Muriel WJ, Bridges BA (1976) Use of a simplified fluctuation test to detect low levels of mutagens. Mutat Res 38:33–42PubMedGoogle Scholar
  36. Hartman PE, Ames BN, Roth JR, Barnes WM, Levin DE (1986) Target sequences for mutagenesis in Salmonella histidine-requiring mutants. Environ Mutagen 8:631–641PubMedCrossRefGoogle Scholar
  37. Hass BS, Heflich RH, Shaddock JG, Casciano DA (1985) Comparison of mutagenicities in a Salmonella reversion assay mediated by uninduced hepatocytes and hepato- cytes from rats pretreated for 1 or 5 days with aroclor 1254. Environ Mutagen 7:391–403PubMedCrossRefGoogle Scholar
  38. Houk VS, Schalkowsky S, Claxton LD (1988) Development and validation of an automated approach to bacterial mutagenicity testing. Environ Molec Mutagen [Suppl 11] 11:49Google Scholar
  39. Hubbard SA, Green MHL, Gatehouse D, Bridges JW (1984) The fluctuation test in bacteria. In: Obey BJ, Legator M, Nichols W, Ramel C (eds) Handbook of mutagenicity test procedures, 2nd edn. Elsevier, Amsterdam, pp 141–160Google Scholar
  40. Hubbard SA, Brooks TM, Gonzalez LP, Bridges JW (1985) Preparation and characterisation of S9 fractions. In: Parry JM, Arlett CF (eds) Comparative genetic toxicology: the second UKEMS collaborative study. Macmillan, London, pp 413–438Google Scholar
  41. ICPEMC (1982) International commission for protection against environmental mutagens and carcinogens: committee 2 final report. Mutagenesis testing as an approach to carcinogenesis. Mutat Res 99:73–91Google Scholar
  42. Kada T, Tutikawa K, Sadaie Y (1972) In vitro and host-mediated “rec-Assay” procedures for screening chemical mutagens; and phloxine, a mutagenic red dye detected. Mutat Res 16:165–174PubMedCrossRefGoogle Scholar
  43. Kier LD, Yamasaki E, Ames BN (1974) Detection of mutagenic activity in cigarette smoke condensate. Proc Natl Acad Sci USA 71:4159–4163PubMedCrossRefGoogle Scholar
  44. Lefevre PA, Ashby J (1981) The effects of pre-incubation period and norharman on the mutagenic potency of 4-dimethylaminoazobenzene and 3’-methyl-4-dimethylamino- azobenzene. Carcinogenesis 2:927–931PubMedCrossRefGoogle Scholar
  45. Levin DE, Hollstein M, Christman MF, Schwiers EA, Ames BN (1982) A new Salmonella tester strain (TA102) with AT base pairs at the site of mutation detects oxidative mutagens. Proc Natl Acad Sci USA 79:7445–7449PubMedCrossRefGoogle Scholar
  46. Litterst CL, Farber TM, Baker AM, Van Looen EJ (1972) Effect of polychlorinated biphenyls on hepatic microsomal enzymes in the rat. Toxicol Appl Pharmacol 23:112–122PubMedCrossRefGoogle Scholar
  47. Longstaff E, McGregor DB (1978) Mutagenicity of a halocarbon refrigerant monochloro- difluoromethane (R-22) in Salmonella typhimurium. Toxicol Lett 2:1–4CrossRefGoogle Scholar
  48. Longstaff E, Robinson M, Bradbrook C, Styles JA, Purchase IFH (1984) Genotoxicity and carcinogenicity of fluorocarbons: assessment by short-term in vitro tests and chronic exposure in rats. Toxicol Appl Pharmacol 72:15–31PubMedCrossRefGoogle Scholar
  49. Luria SE, Delbruck M (1943) Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491–511PubMedGoogle Scholar
  50. MacGregor JT, Sacks LE (1976) The sporulation system of Bacillus subtilis as the basis of a multi-gene mutagen screening test. Mutat Res 38:271–286PubMedGoogle Scholar
  51. Malaveille C, Brun G, Bartsch H (1983) Studies on the efficiency of the Salmonella/rat hepatocyte assay for the detection of carcinogens as mutagens: activation of 1,2- dimethylhydrazine and procarbazine into bacterial mutagens. Carcinogenesis 4:449–455PubMedCrossRefGoogle Scholar
  52. Mailing HV (1966) Mutagenicity of two potent carcinogens, dimethylnitrosamine and diethylnitrosamine, inNeurospora crassa. Mutat Res 3:537–540CrossRefGoogle Scholar
  53. Mailing HV (1971) Dimethylnitrosamine: formation of mutagenic compounds by interaction with mouse liver microsomes. Mutat Res 13:425–429CrossRefGoogle Scholar
  54. Mamber SW, Bryson V, Katz SE (1984) Evaluation of the Escherichia coli K12 inductest for detection of potential chemical carcinogens. Mutat Res 130:141–151PubMedGoogle Scholar
  55. Maron DM, Ames BN (1983) Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215PubMedGoogle Scholar
  56. McCann J, Ames BN (1976) Detection of carcinogens as mutagens in the Sal- monella/microsomQ test: assay of 300 chemicals: discussion. Proc Natl Acad Sci USA 73:950–954PubMedCrossRefGoogle Scholar
  57. McCann J, Spingarn NE, Kobori J, Ames BN (1975 a) Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. Proc Natl Acad Sci USA 72:979–983PubMedCrossRefGoogle Scholar
  58. McCann J, Choi E, Yamasaki E, Ames BN (1975 b) Detection of carcinogens as mutagens in the Salmonella!microsome test: assay of 300 chemicals. Proc Natl Acad Sci USA 72:5135–5139PubMedCrossRefGoogle Scholar
  59. McMahon RE, Cline JC, Thompson CZ (1979) Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens. Cancer Res 39:682–693PubMedGoogle Scholar
  60. Miller JA, Miller EC (1953) The carcinogenic aminoazo dyes. Adv Cancer Res 1:339–396PubMedCrossRefGoogle Scholar
  61. Mirsalis JC, Hamm TE Jr, Sherrill JM, Butterworth BE (1982) The role of gut flora in the genotoxicity of dinitro toluene. Nature 295:322–323PubMedCrossRefGoogle Scholar
  62. Mohn GR, Ellenberger J (1977) The use ofEscherichia coli Kl2/343/113(A) as a multipurpose indicator strain in various mutagenicity testing procedures. In: Kilbey BJ, Legator M, Nichols W, Ramel C (eds) Handbook of mutagenicity test procedures. Elsevier, Amsterdam, pp 95–118Google Scholar
  63. Nakamura S-I, Oda Y, Shimada T, Oki I, Sugimoto K (1987) SOS-inducing activity of chemical carcinogens and mutagens in Salmonella typhimurium TA1535/pSK1002: examination with 151 chemicals. Mutat Res 192:239–246PubMedCrossRefGoogle Scholar
  64. Nash JA, King LJ, Lock EA, Green T (1984) The metabolism and disposition of hexachloro-l,3-butadiene in the rat and its relevance to nephrotoxicity. Toxicol Appl Pharmacol 73:124–137PubMedCrossRefGoogle Scholar
  65. OECD (1983 a) Guidelines for testing of chemicals: 471: Genetic toxicology: Salmonella typhimurium, reverse mutation assay. Organisation for Economic Co-operation and Development, ParisGoogle Scholar
  66. OECD (1983 b) Guidelines for testing of chemicals: 472: Genetic toxicology: Escherichia coli, reverse mutation assay. Organisation for Economic Co-operation and Development, ParisGoogle Scholar
  67. Oftedal P (1979) Extrapolation of mutagenic test results to man. In: Paget GE (ed) Mutagenesis in sub-mammalian systems: status and significance. MTP Press, Lancaster, pp 189–194Google Scholar
  68. Paolini M, Hrelia P, Corsi C, Bronzetti G, Biagi GL, Cantelli-Forti G (1987) NADPH as a rate-limiting factor for microsomal metabolism. An alternative and economic NADPH-generating system for microsomal monooxygenase in in vitro genotoxicity studies. Mutat Res 178:11–20PubMedCrossRefGoogle Scholar
  69. Pitot HC, Barsness L, Goldsworthy T, Kitagawa T (1978) Biochemical characterization of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature 271:456–458PubMedCrossRefGoogle Scholar
  70. Prival MJ, Bell SJ, Mitchell VD, Peiperl MD, Vaughn VL (1984) Mutagenicity of benzidine and benzidine-congener dyes and selected monoazo dyes in a modified Salmonella assay. Mutat Res 136:33–47PubMedCrossRefGoogle Scholar
  71. Quillardet P, Huisman O, D’ari R, Hofnung M (1982) SOS chromotest, a direct assay of induction of an SOS function in Escherichia coli K-12 to measure genotoxicity. Proc Natl Acad Sei USA 79:5971–5975CrossRefGoogle Scholar
  72. Rannug U, Johansson A, Ramel C, Wachmeister CA (1974) The mutagenicity of vinyl chloride after metabolic activation. Ambio 3:194–197Google Scholar
  73. Robertson J, Harris WJ, McGregor DB (1982 a) Mutagenicity of azo-dyes in theSalmonella/activation test. Carcinogenesis 3:21–25PubMedCrossRefGoogle Scholar
  74. Robertson J, Harris WJ, McGregor DB (1982 b) Factors affecting the response ofN,N- dimethylaminoazobenzene in the Ames microbial mutation assay. Carcinogenesis 3:977–980PubMedCrossRefGoogle Scholar
  75. Rosenkranz HS, Speck WT (1975) Mutagenicity of metronidazole: activation by mammalian liver microsomes. Biochem Biophys Res Commun 66:520–525PubMedCrossRefGoogle Scholar
  76. Rosenkranz HS, Speck WT (1976) Activation of nitrofurantoin to a mutagen by rat liver nitroreductase. Biochem Pharmacol 25:1555–1556PubMedCrossRefGoogle Scholar
  77. Rosenkranz HS, McCoy EC, Mermelstein R, Speck WT (1981) A cautionary note on the use of nitroreductase-deflcient strains of Salmonella typhimurium for the detection of nitroarenes as mutagens in complex mixtures including diesel exhausts. Mutat Res 91:103–105PubMedCrossRefGoogle Scholar
  78. Rosenkranz EJ, McCoy EC, Mermelstein R, Rosenkranz HS (1982) Evidence for the existence of distinct nitroreductases in Salmonella typhimurium roles in mutagenesis. Carcinogenesis 3:121–123PubMedCrossRefGoogle Scholar
  79. Ruiz-Vazquez R, Pueyo C, Cera-olmedo E (1978) A mutagen assay detecting forward mutations in an arabinose-sensitive strain ofSalmonella typhimurium. Mutat Res 54:121–129PubMedGoogle Scholar
  80. Ryan FJ (1955) Spontaneous mutation in non-dividing bacteria. Genetics 40:726–738PubMedGoogle Scholar
  81. Simmon VF (1981) Applications of the Sa/raorae/Zfl/microsome assay. In: Stich HF, San RHC (eds) Short-term tests for chemical carcinogens. Springer, Berlin Heidelberg New York, pp 120–126CrossRefGoogle Scholar
  82. Skopek TR, Liber HL, Krolewski JJ, Thilly WG (1978) Quantitative forward mutation assay in Salmonella typhimurium, using 8-azaguanine resistance as a genetic marker. Proc Natl Acad Sei USA 75:410–414CrossRefGoogle Scholar
  83. Styles JA, Richardson CR, Callander RD, Cross MF, Bennett IP, Longstaff E (1985) Activity of bromochlorodifluoromethane (BCF) in three mutation tests. Mutat Res 142:187–192PubMedCrossRefGoogle Scholar
  84. Tanooka H (1977) Development and applications of Bacillus subtilis test systems for mutagens, involving DNA-repair deficiency and suppressible auxotrophic mutations. Mutat Res 42:19–32PubMedCrossRefGoogle Scholar
  85. Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, Minor R (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236:933–941PubMedCrossRefGoogle Scholar
  86. Venitt S, Bushell CT, Osborne M (1977) Mutagenicity of acrylonitrile (cyanoethylene) in Escherichia coli. Mutat Res 45:283–288PubMedCrossRefGoogle Scholar
  87. Venitt S, Forster R, Longstaff E (1983) Bacterial mutation assays. In: Report of the UKEMS sub-committee on guidelines for mutagenicity testing. Part 1: Basic test battery; minimal criteria; professional standards; interpretation; selection of supplementary assays. The United Kingdom Environmental Mutagen Society, Swansea, pp 5–40Google Scholar
  88. Venitt S, Crofton-Sleigh C, Osborne MR (1984) The hair-dye reagent 2-(2’,4’- diaminophenoxy)ethanol is mutagenic to Salmonella typhimurium. Mutat Res 135:31–47PubMedCrossRefGoogle Scholar
  89. Victorin K, Stahlberg M (1988) A method for studying the mutagenicity of some gaseous compounds in Salmonella typhimurium. Environ Molec Mutagen 11:65–77CrossRefGoogle Scholar
  90. Voogd CE, van der Stel JJ, Jacobs J (1974) The mutagenetic action of nitroimidazoles. I. Metronidazole, nimorazole, dimetridazole and ronidazole. Mutat Res 26:483–490PubMedCrossRefGoogle Scholar
  91. Wright AS (1980) ICPEMC working paper 2/2: the role of metabolism in chemical mutagenesis and chemical carcinogenesis. Mutat Res 75:215–241PubMedGoogle Scholar
  92. Wolf U (1974) Theodor Boveri and his book,On the problem of the origin of malignant tumors. In: German J (ed) Chromosomes and cancer. Wiley, New York, pp 3–20Google Scholar
  93. Yahagi T, Degawa M, Seino Y, Matsushima T, Nagao M, Sugimura T, Hashimoto Y (1975) Mutagenicity of carcinogen azo dyes and their derivatives. Cancer Lett 1:91–96PubMedCrossRefGoogle Scholar
  94. Yahagi T, Nagao M, Seino Y, Matsushima T, Sugimura T, Okado M (1977) Mutagenicities of N-nitrosamines onSalmonella. Mutat Res 48:121–130PubMedCrossRefGoogle Scholar
  95. Zeiger E, Haworth S (1985) Tests with a preincubation modification of the Sal- monellalmicrosome assay. In: Ashby J, de Serres FJ, Draper M, Ishidate M Jr, Margolin BH, Matter BE, Shelby MD (eds) Evaluation of short-term tests for carcinogens. Report of the international programme on chemical safety’s collaborative study on in vitro assays. Elsevier, Amsterdam, pp 187–199 (Progress in mutation research, vol 5)Google Scholar
  96. Zeiger E, Risko KJ, Margolin BH (1985) Strategies to reduce the cost of mutagenicity screening with the Salmonella assay. Environ Mutagen 7:901–911PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • R. D. Callander

There are no affiliations available

Personalised recommendations